Biopharmas raising money in public or private financings, including: Compass, Fluogide, IGM.

New hires and promotions in the biopharma industry, including: Akari, Coya, Cytovation, EMD Serono, FSD, Oncoinvent, Small, Visiox.

The top 10 med-tech stock gainers and losers for the week.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alma, Biotricity, Centogene, Fortrea, Labcorp, Lca Automation, Lifera, Lumiraxx, Mediwound, Novacyt, Rewalk Robotics, Shl Medical, Yourgene Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lunit.

Med-tech firms raising money in public or private financings, including: Xtant Medical.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Argenx, Biomarin, Drug Farm, Madrigal, Merus, Scisparc, Unicycive, Zai Lab.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Alvotech, Amgen, Boehringer Ingelheim, Celltrion, Coherus, Fresenius, Organon, Samsung Bioepis, Sandoz, Shionogi, Tonix, Zymedi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Capricor, Cyclo, Enterome, Genfit, Ipsen, Kyverna, Neuren, Pharmaessentia, PTC, Sanofi Pasteur, SK.